RxDoctor Payments Data

Thomas Williams, MD

Family Medicine · Oak Grove, LANPI 1467422048

Payments from drug & device makers

$1,661in general payments, 2019–2025

Across 82 payments — averaging $20.25 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Bayer$366
  • AstraZeneca$166
  • Merck$163
  • GSK$155
  • Amgen$150
  • Lilly USA, LLC$147
  • plus $515 from 11 others

What the payments were for

  • Food & beverage$1,58896%
  • Education$724%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,661 in reported general payments places this provider in the 65th percentile of 1,469 family medicine providers in Louisiana.

See all family medicine providers in Louisiana

Medicare billing

Part B allowed, 2024
$8,624
Medicare patients
28
Services billed
109

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
MounjaroTirzepatide222$220,163
OzempicSemaglutide153$149,553
EliquisApixaban275$149,501
JardianceEmpagliflozin187$136,776
Trelegy ElliptaFluticasone/Umeclidin/Vilanter98$92,159
FarxigaDapagliflozin Propanediol94$89,011
JanuviaSitagliptin Phosphate35$36,517
EntrestoSacubitril/Valsartan49$32,985
LinzessLinaclotide55$28,940
Janumet XrSitagliptin Phos/Metformin Hcl30$25,812
RybelsusSemaglutide22$24,356
Breztri AerosphereBudesonide/Glycopyr/Formoterol25$23,664
Stiolto RespimatTiotropium Br/Olodaterol Hcl32$21,522
FycompaPerampanel14$17,808
MyrbetriqMirabegron53$17,707

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Lilly USA, LLCMounjaro, Trulicity$147$232,407235 claims
Boehringer IngelheimJardiance, Stiolto Respimat, Combivent Respimat$87$163,939231 claims
PfizerEliquis$37$149,501275 claims
AstraZenecaFarxiga, Breztri Aerosphere$166$112,675119 claims
GSKTrelegy Ellipta, Anoro Ellipta, Breo Ellipta$155$108,587132 claims
MerckJanuvia, Janumet Xr$163$62,32965 claims
NovartisEntresto$72$32,98549 claims
AbbVieLinzess$46$28,94055 claims
Salix Pharmaceuticals, A Division Of Bausch Health US, LLCTrulance$43$14,12335 claims
BayerKerendia$366$9,40713 claims
Sanofi-aventis U.S. LLCLantus$89$4,65043 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 65th percentile of 1,469 family medicine providers in Louisiana.

Other family medicine in Oak Grove

See the full list for Louisiana

Where these figures come from

Is this you, or does something look wrong? →